Skip to main content

Specialty Pharmacy

  • BIO calls for different names for biosimilars, branded biotech drugs

    NEW YORK — In what is emerging as the latest battle over follow-on biologics, a new argument has emerged about what to call them, and supporters of biotechnology companies are the latest to take a shot.

  • Depomed launches Lazanda nasal spray for breakthrough pain in cancer patients

    NEWARK, Calif. — Depomed has launched a new drug for breakthrough pain in cancer patients, the company said Monday.

    The drug maker announced the launch of Lazanda (fentanyl) nasal spray, meant for treating adults who are taking opioid painkillers, but have become tolerant to them. The company also have launched a Signature Support Program designed to streamline patient access to the drug, including reimbursement and co-pay assistance. Other benefits of the program include prescription reminders and eligibility for one month's supply for free.

  • FDA introduces e-learning program about untruthful, misleading drug ads

    SILVER SPRING, Md. — The Food and Drug Administration has launched an online learning course aimed at healthcare professionals to educate them about potentially untruthful or misleading drug ads and promotional materials.

  • Walgreens collects donations for Susan G. Komen

    DALLAS — Walgreens is collecting donations for breast cancer treatment through a partnership with Susan G. Komen to mark National Breast Cancer Awareness Month, which takes place this month.

  • FDA Antiviral Drugs Advisory Committee recommends approval for J&J hepatitis C drug

    NEW YORK — A Food and Drug Administration expert panel has recommended approval for a drug made by Johnson & Johnson for treating hepatitis C, the company said.

    J&J subsidiary Janssen Research & Development said the 19-member FDA Antiviral Drugs Advisory Committee voted unanimously to recommend approval for TMC435 (simeprevir), a 150-mg drug meant for administration once per day with the generic antiviral ribavirin and a biotech drug known as an interferon, for treating genotype 1 chronic hepatitis C.

  • All American Pet Co. to sell NutraBars for dogs at Albertsons

    LOS ANGELES — Albertsons has placed an order for what is being called the "first true food bar" for dogs.

    All American Pet Co. said Friday it received an order from the grocer for NutraBars, which are designed to be high in protein and low in fat, and are made in the United States.

    The company said it also was expecting an order for Chewies Dog Treats, which are all-natural and made with peanuts, cheese and bacon. Albertsons, based in Boise, Idaho, operates 1,119 stores under 12 banners in 29 states.

     

  • FDA to recommend rescheduling of opioid painkiller hydrocodone from CIII to CII

    SILVER SPRING, Md. — The Food and Drug Administration plans to recommend stronger regulations for a commonly used opioid painkiller.

  • NASP launches medical marijuana task force

    ALEXANDRIA, Va. — The National Association of Specialty Pharmacy has launched a task force to investigate pharmacological management of medical marijuana, the group said.

    Currently, according to NASP, there are no national standards of practice for the management of medical marijuana, though according to the National Organization for the Reform of Marijuana Laws, 21 states and the District of Columbia have legalized marijuana for medical purposes. Two of those states, Washington and Colorado, have legalized recreational use as well.

X
This ad will auto-close in 10 seconds